Compounds of the formula (I), in which R, X, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have the meanings indicated in Claim (1), are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours. ##STR00001##

 
Web www.patentalert.com

< N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases

> Substituted biaryl piperazinyl-pyridine analogues

> Indazole having analgesic activity

~ 00580